カテゴリー： LP Information, 世界, 医療/バイオ

世界の複合ホルモン避妊薬市場予測 2021年-2026年

【英語タイトル】Global Combined Hormonal Contraceptives Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9487）・商品コード：LPI21MY9487
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：139
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「複合ホルモン避妊薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、15〜24歳、25〜34歳、35〜44歳、44歳以上など、用途別には、病院、家庭、クリニックなどにセグメント区分してまとめました。複合ホルモン避妊薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・複合ホルモン避妊薬の世界市場概要（サマリー）
・複合ホルモン避妊薬の企業別販売量・売上
・複合ホルモン避妊薬の企業別市場シェア
・複合ホルモン避妊薬の世界市場規模 2016年-2021年：種類別（15〜24歳、25〜34歳、35〜44歳、44歳以上）
・複合ホルモン避妊薬の世界市場規模 2016年-2021年：用途別（病院、家庭、クリニック）
・複合ホルモン避妊薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・複合ホルモン避妊薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・複合ホルモン避妊薬のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・複合ホルモン避妊薬の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・複合ホルモン避妊薬市場の成長要因・課題・動向
・複合ホルモン避妊薬の世界市場予測 2021年-2026年
・複合ホルモン避妊薬の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・複合ホルモン避妊薬のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・複合ホルモン避妊薬のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・複合ホルモン避妊薬の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・複合ホルモン避妊薬の世界市場予測：種類別（15〜24歳、25〜34歳、35〜44歳、44歳以上）
・複合ホルモン避妊薬の世界市場予測：用途別（病院、家庭、クリニック）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Combined Hormonal Contraceptives will have significant change from previous year. By the most conservative estimates of global Combined Hormonal Contraceptives market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 17400 million in 2019. Over the next five years the Combined Hormonal Contraceptives market will register a 3.4% CAGR in terms of revenue, the global market size will reach US$ 19890 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Combined Hormonal Contraceptives market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
15-24 years
25-34 years
35-44 years
Above 44 years

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospitals
Household
Clinics

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Actavis
Agile Therapeutics
Allergan
Bayer
Teva Pharmaceutical Industries
ANI Pharmaceuticals
Ortho-McNeil-Janssen Pharmaceuticals
Noven Pharmaceuticals
Johnson & Johnson
Mylan

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Combined Hormonal Contraceptives Consumption 2016-2026
2.1.2 Combined Hormonal Contraceptives Consumption CAGR by Region
2.2 Combined Hormonal Contraceptives Segment by Type
2.2.1 15-24 years
2.2.2 25-34 years
2.2.3 35-44 years
2.2.4 Above 44 years
2.3 Combined Hormonal Contraceptives Sales by Type
2.3.1 Global Combined Hormonal Contraceptives Sales Market Share by Type (2016-2021)
2.3.2 Global Combined Hormonal Contraceptives Revenue and Market Share by Type (2016-2021)
2.3.3 Global Combined Hormonal Contraceptives Sale Price by Type (2016-2021)
2.4 Combined Hormonal Contraceptives Segment by Application
2.4.1 Hospitals
2.4.2 Household
2.4.3 Clinics
2.5 Combined Hormonal Contraceptives Sales by Application
2.5.1 Global Combined Hormonal Contraceptives Sale Market Share by Application (2016-2021)
2.5.2 Global Combined Hormonal Contraceptives Revenue and Market Share by Application (2016-2021)
2.5.3 Global Combined Hormonal Contraceptives Sale Price by Application (2016-2021)

3 Global Combined Hormonal Contraceptives by Company
3.1 Global Combined Hormonal Contraceptives Sales Market Share by Company
3.1.1 Global Combined Hormonal Contraceptives Sales by Company (2019-2021)
3.1.2 Global Combined Hormonal Contraceptives Sales Market Share by Company (2019-2021)
3.2 Global Combined Hormonal Contraceptives Revenue Market Share by Company
3.2.1 Global Combined Hormonal Contraceptives Revenue by Company (2019-2021)
3.2.2 Global Combined Hormonal Contraceptives Revenue Market Share by Company (2019-2021)
3.3 Global Combined Hormonal Contraceptives Sale Price by Company
3.4 Global Manufacturers Combined Hormonal Contraceptives Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Combined Hormonal Contraceptives Product Location Distribution
3.4.2 Players Combined Hormonal Contraceptives Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Combined Hormonal Contraceptives by Region
4.1 Global Combined Hormonal Contraceptives by Region
4.1.1 Global Combined Hormonal Contraceptives Sales by Region
4.1.2 Global Combined Hormonal Contraceptives Revenue by Region
4.2 Americas Combined Hormonal Contraceptives Sales Growth
4.3 APAC Combined Hormonal Contraceptives Sales Growth
4.4 Europe Combined Hormonal Contraceptives Sales Growth
4.5 Middle East & Africa Combined Hormonal Contraceptives Sales Growth

5 Americas
5.1 Americas Combined Hormonal Contraceptives Sales by Country
5.1.1 Americas Combined Hormonal Contraceptives Sales by Country (2016-2021)
5.1.2 Americas Combined Hormonal Contraceptives Revenue by Country (2016-2021)
5.2 Americas Combined Hormonal Contraceptives Sales by Type
5.3 Americas Combined Hormonal Contraceptives Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Combined Hormonal Contraceptives Sales by Region
6.1.1 APAC Combined Hormonal Contraceptives Sales by Region (2016-2021)
6.1.2 APAC Combined Hormonal Contraceptives Revenue by Region (2016-2021)
6.2 APAC Combined Hormonal Contraceptives Sales by Type
6.3 APAC Combined Hormonal Contraceptives Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Combined Hormonal Contraceptives by Country
7.1.1 Europe Combined Hormonal Contraceptives Sales by Country (2016-2021)
7.1.2 Europe Combined Hormonal Contraceptives Revenue by Country (2016-2021)
7.2 Europe Combined Hormonal Contraceptives Sales by Type
7.3 Europe Combined Hormonal Contraceptives Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Combined Hormonal Contraceptives by Country
8.1.1 Middle East & Africa Combined Hormonal Contraceptives Sales by Country (2016-2021)
8.1.2 Middle East & Africa Combined Hormonal Contraceptives Revenue by Country (2016-2021)
8.2 Middle East & Africa Combined Hormonal Contraceptives Sales by Type
8.3 Middle East & Africa Combined Hormonal Contraceptives Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Combined Hormonal Contraceptives Distributors
10.3 Combined Hormonal Contraceptives Customer

11 Global Combined Hormonal Contraceptives Market Forecast
11.1 Global Combined Hormonal Contraceptives Forecast by Region
11.1.1 Global Combined Hormonal Contraceptives Forecast by Regions (2021-2026)
11.2.2 Global Combined Hormonal Contraceptives Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Combined Hormonal Contraceptives Forecast by Type
11.7 Global Combined Hormonal Contraceptives Forecast by Application

12 Key Players Analysis
12.1 Actavis
12.1.1 Actavis Actavis Company Information
12.1.2 Actavis Combined Hormonal Contraceptives Product Offered
12.1.3 Actavis Combined Hormonal Contraceptives Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Actavis Main Business Overview
12.1.5 Actavis Latest Developments
12.2 Agile Therapeutics
12.2.1 Agile Therapeutics Company Information
12.2.2 Agile Therapeutics Combined Hormonal Contraceptives Product Offered
12.2.3 Agile Therapeutics Combined Hormonal Contraceptives Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Agile Therapeutics Main Business Overview
12.2.5 Agile Therapeutics Latest Developments
12.3 Allergan
12.3.1 Allergan Company Information
12.3.2 Allergan Combined Hormonal Contraceptives Product Offered
12.3.3 Allergan Combined Hormonal Contraceptives Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Allergan Main Business Overview
12.3.5 Allergan Latest Developments
12.4 Bayer
12.4.1 Bayer Company Information
12.4.2 Bayer Combined Hormonal Contraceptives Product Offered
12.4.3 Bayer Combined Hormonal Contraceptives Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Bayer Main Business Overview
12.4.5 Bayer Latest Developments
12.5 Teva Pharmaceutical Industries
12.5.1 Teva Pharmaceutical Industries Company Information
12.5.2 Teva Pharmaceutical Industries Combined Hormonal Contraceptives Product Offered
12.5.3 Teva Pharmaceutical Industries Combined Hormonal Contraceptives Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Teva Pharmaceutical Industries Main Business Overview
12.5.5 Teva Pharmaceutical Industries Latest Developments
12.6 ANI Pharmaceuticals
12.6.1 ANI Pharmaceuticals Company Information
12.6.2 ANI Pharmaceuticals Combined Hormonal Contraceptives Product Offered
12.6.3 ANI Pharmaceuticals Combined Hormonal Contraceptives Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 ANI Pharmaceuticals Main Business Overview
12.6.5 ANI Pharmaceuticals Latest Developments
12.7 Ortho-McNeil-Janssen Pharmaceuticals
12.7.1 Ortho-McNeil-Janssen Pharmaceuticals Company Information
12.7.2 Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Product Offered
12.7.3 Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Ortho-McNeil-Janssen Pharmaceuticals Main Business Overview
12.7.5 Ortho-McNeil-Janssen Pharmaceuticals Latest Developments
12.8 Noven Pharmaceuticals
12.8.1 Noven Pharmaceuticals Company Information
12.8.2 Noven Pharmaceuticals Combined Hormonal Contraceptives Product Offered
12.8.3 Noven Pharmaceuticals Combined Hormonal Contraceptives Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Noven Pharmaceuticals Main Business Overview
12.8.5 Noven Pharmaceuticals Latest Developments
12.9 Johnson & Johnson
12.9.1 Johnson & Johnson Company Information
12.9.2 Johnson & Johnson Combined Hormonal Contraceptives Product Offered
12.9.3 Johnson & Johnson Combined Hormonal Contraceptives Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Johnson & Johnson Main Business Overview
12.9.5 Johnson & Johnson Latest Developments
12.10 Mylan
12.10.1 Mylan Company Information
12.10.2 Mylan Combined Hormonal Contraceptives Product Offered
12.10.3 Mylan Combined Hormonal Contraceptives Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Mylan Main Business Overview
12.10.5 Mylan Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Combined Hormonal Contraceptives Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of 15-24 years
Table 3. Major Players of 25-34 years
Table 4. Major Players of 35-44 years
Table 5. Major Players of Above 44 years
Table 6. Global Combined Hormonal Contraceptives Sales by Type (2016-2021) & (K MT)
Table 7. Global Combined Hormonal Contraceptives Sales Market Share by Type (2016-2021)
Table 8. Global Combined Hormonal Contraceptives Revenue by Type (2016-2021) & ($ million)
Table 9. Global Combined Hormonal Contraceptives Revenue Market Share by Type (2016-2021)
Table 10. Global Combined Hormonal Contraceptives Sale Price by Type (2016-2021)
Table 11. Global Combined Hormonal Contraceptives Sales by Application (2016-2021) & (K MT)
Table 12. Global Combined Hormonal Contraceptives Sales Market Share by Application (2016-2021)
Table 13. Global Combined Hormonal Contraceptives Value by Application (2016-2021)
Table 14. Global Combined Hormonal Contraceptives Revenue Market Share by Application (2016-2021)
Table 15. Global Combined Hormonal Contraceptives Sale Price by Application (2016-2021)
Table 16. Global Combined Hormonal Contraceptives Sales by Company (2019-2021) & (K MT)
Table 17. Global Combined Hormonal Contraceptives Sales Market Share by Company (2019-2021)
Table 18. Global Combined Hormonal Contraceptives Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Combined Hormonal Contraceptives Revenue Market Share by Company (2019-2021)
Table 20. Global Combined Hormonal Contraceptives Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Combined Hormonal Contraceptives Producing Area Distribution and Sales Area
Table 22. Players Combined Hormonal Contraceptives Products Offered
Table 23. Combined Hormonal Contraceptives Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Combined Hormonal Contraceptives Sales by Region (2016-2021) (K MT)
Table 27. Global Combined Hormonal Contraceptives Sales Market Share by Region (2016-2021)
Table 28. Global Combined Hormonal Contraceptives Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Combined Hormonal Contraceptives Revenue Market Share by Region (2016-2021)
Table 30. Americas Combined Hormonal Contraceptives Sales by Country (2016-2021) & (K MT)
Table 31. Americas Combined Hormonal Contraceptives Sales Market Share by Country (2016-2021)
Table 32. Americas Combined Hormonal Contraceptives Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Combined Hormonal Contraceptives Revenue Market Share by Country (2016-2021)
Table 34. Americas Combined Hormonal Contraceptives Sales by Type (2016-2021) & (K MT)
Table 35. Americas Combined Hormonal Contraceptives Sales Market Share by Type (2016-2021)
Table 36. Americas Combined Hormonal Contraceptives Sales by Application (2016-2021) & (K MT)
Table 37. Americas Combined Hormonal Contraceptives Sales Market Share by Application (2016-2021)
Table 38. APAC Combined Hormonal Contraceptives Sales by Region (2016-2021) & (K MT)
Table 39. APAC Combined Hormonal Contraceptives Sales Market Share by Region (2016-2021)
Table 40. APAC Combined Hormonal Contraceptives Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Combined Hormonal Contraceptives Revenue Market Share by Region (2016-2021)
Table 42. APAC Combined Hormonal Contraceptives Sales by Type (2016-2021) & (K MT)
Table 43. APAC Combined Hormonal Contraceptives Sales Market Share by Type (2016-2021)
Table 44. APAC Combined Hormonal Contraceptives Sales by Application (2016-2021) & (K MT)
Table 45. APAC Combined Hormonal Contraceptives Sales Market Share by Application (2016-2021)
Table 46. Europe Combined Hormonal Contraceptives Sales by Country (2016-2021) & (K MT)
Table 47. Europe Combined Hormonal Contraceptives Sales Market Share by Country (2016-2021)
Table 48. Europe Combined Hormonal Contraceptives Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Combined Hormonal Contraceptives Revenue Market Share by Country (2016-2021)
Table 50. Europe Combined Hormonal Contraceptives Sales by Type (2016-2021) & (K MT)
Table 51. Europe Combined Hormonal Contraceptives Sales Market Share by Type (2016-2021)
Table 52. Europe Combined Hormonal Contraceptives Sales by Application (2016-2021) & (K MT)
Table 53. Europe Combined Hormonal Contraceptives Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Combined Hormonal Contraceptives Sales by Country (2016-2021) & (K MT)
Table 55. Middle East & Africa Combined Hormonal Contraceptives Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Combined Hormonal Contraceptives Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Combined Hormonal Contraceptives Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Combined Hormonal Contraceptives Sales by Type (2016-2021) & (K MT)
Table 59. Middle East & Africa Combined Hormonal Contraceptives Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Combined Hormonal Contraceptives Sales by Application (2016-2021) & (K MT)
Table 61. Middle East & Africa Combined Hormonal Contraceptives Sales Market Share by Application (2016-2021)
Table 62. Global Combined Hormonal Contraceptives Sales Forecast by Type (2021-2026) & (K MT)
Table 63. Global Combined Hormonal Contraceptives Sales Market Share Forecast by Type (2021-2026)
Table 64. Global Combined Hormonal Contraceptives Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 65. Global Combined Hormonal Contraceptives Revenue Market Share Forecast by Type (2021-2026)
Table 66. Global Combined Hormonal Contraceptives Sales Forecast by Application (2021-2026) & (K MT)
Table 67. Global Combined Hormonal Contraceptives Sales Market Share Forecast by Application (2021-2026)
Table 68. Global Combined Hormonal Contraceptives Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 69. Global Combined Hormonal Contraceptives Revenue Market Share Forecast by Application (2021-2026)
Table 70. Actavis Basic Information, Combined Hormonal Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 71. Actavis Combined Hormonal Contraceptives Product Offered
Table 72. Actavis Combined Hormonal Contraceptives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 73. Actavis Main Business
Table 74. Actavis Latest Developments
Table 75. Agile Therapeutics Basic Information, Combined Hormonal Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 76. Agile Therapeutics Combined Hormonal Contraceptives Product Offered
Table 77. Agile Therapeutics Combined Hormonal Contraceptives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 78. Agile Therapeutics Main Business
Table 79. Agile Therapeutics Latest Developments
Table 80. Allergan Basic Information, Combined Hormonal Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 81. Allergan Combined Hormonal Contraceptives Product Offered
Table 82. Allergan Combined Hormonal Contraceptives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 83. Allergan Main Business
Table 84. Allergan Latest Developments
Table 85. Bayer Basic Information, Combined Hormonal Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 86. Bayer Combined Hormonal Contraceptives Product Offered
Table 87. Bayer Combined Hormonal Contraceptives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 88. Bayer Main Business
Table 89. Bayer Latest Developments
Table 90. Teva Pharmaceutical Industries Basic Information, Combined Hormonal Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 91. Teva Pharmaceutical Industries Combined Hormonal Contraceptives Product Offered
Table 92. Teva Pharmaceutical Industries Combined Hormonal Contraceptives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 93. Teva Pharmaceutical Industries Main Business
Table 94. Teva Pharmaceutical Industries Latest Developments
Table 95. ANI Pharmaceuticals Basic Information, Combined Hormonal Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 96. ANI Pharmaceuticals Combined Hormonal Contraceptives Product Offered
Table 97. ANI Pharmaceuticals Combined Hormonal Contraceptives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 98. ANI Pharmaceuticals Main Business
Table 99. ANI Pharmaceuticals Latest Developments
Table 100. Ortho-McNeil-Janssen Pharmaceuticals Basic Information, Combined Hormonal Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 101. Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Product Offered
Table 102. Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 103. Ortho-McNeil-Janssen Pharmaceuticals Main Business
Table 104. Ortho-McNeil-Janssen Pharmaceuticals Latest Developments
Table 105. Noven Pharmaceuticals Basic Information, Combined Hormonal Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 106. Noven Pharmaceuticals Combined Hormonal Contraceptives Product Offered
Table 107. Noven Pharmaceuticals Combined Hormonal Contraceptives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 108. Noven Pharmaceuticals Main Business
Table 109. Noven Pharmaceuticals Latest Developments
Table 110. Johnson & Johnson Basic Information, Combined Hormonal Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 111. Johnson & Johnson Combined Hormonal Contraceptives Product Offered
Table 112. Johnson & Johnson Combined Hormonal Contraceptives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 113. Johnson & Johnson Main Business
Table 114. Johnson & Johnson Latest Developments
Table 115. Mylan Basic Information, Combined Hormonal Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 116. Mylan Combined Hormonal Contraceptives Product Offered
Table 117. Mylan Combined Hormonal Contraceptives Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 118. Mylan Main Business
Table 119. Mylan Latest Developments
List of Figures
Figure 1. Picture of Combined Hormonal Contraceptives
Figure 2. Combined Hormonal Contraceptives Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Combined Hormonal Contraceptives Sales Growth Rate 2016-2026 (K MT)
Figure 7. Global Combined Hormonal Contraceptives Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Combined Hormonal Contraceptives Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of 15-24 years
Figure 10. Product Picture of 25-34 years
Figure 11. Product Picture of 35-44 years
Figure 12. Product Picture of Above 44 years
Figure 13. Global Combined Hormonal Contraceptives Sales Market Share by Type in 2020
Figure 14. Global Combined Hormonal Contraceptives Revenue Market Share by Type (2016-2021)
Figure 15. Combined Hormonal Contraceptives Consumed in Hospitals
Figure 16. Global Combined Hormonal Contraceptives Market: Hospitals (2016-2021) & (K MT)
Figure 17. Combined Hormonal Contraceptives Consumed in Household
Figure 18. Global Combined Hormonal Contraceptives Market: Household (2016-2021) & (K MT)
Figure 19. Combined Hormonal Contraceptives Consumed in Clinics
Figure 20. Global Combined Hormonal Contraceptives Market: Clinics (2016-2021) & (K MT)
Figure 21. Global Combined Hormonal Contraceptives Sales Market Share by Application (2016-2021)
Figure 22. Global Combined Hormonal Contraceptives Revenue Market Share by Application in 2020
Figure 23. Global Combined Hormonal Contraceptives Revenue Market by Company in 2020 ($ Million)
Figure 24. Global Combined Hormonal Contraceptives Revenue Market Share by Company in 2020
Figure 25. Global Combined Hormonal Contraceptives Sales Market Share by Regions (2016-2021)
Figure 26. Global Combined Hormonal Contraceptives Revenue Market Share by Region in 2020
Figure 27. Americas Combined Hormonal Contraceptives Sales 2016-2021 (K MT)
Figure 28. Americas Combined Hormonal Contraceptives Revenue 2016-2021 ($ Millions)
Figure 29. APAC Combined Hormonal Contraceptives Sales 2016-2021 (K MT)
Figure 30. APAC Combined Hormonal Contraceptives Revenue 2016-2021 ($ Millions)
Figure 31. Europe Combined Hormonal Contraceptives Sales 2016-2021 (K MT)
Figure 32. Europe Combined Hormonal Contraceptives Revenue 2016-2021 ($ Millions)
Figure 33. Middle East & Africa Combined Hormonal Contraceptives Sales 2016-2021 (K MT)
Figure 34. Middle East & Africa Combined Hormonal Contraceptives Revenue 2016-2021 ($ Millions)
Figure 35. Americas Combined Hormonal Contraceptives Sales Market Share by Country in 2020
Figure 36. Americas Combined Hormonal Contraceptives Revenue Market Share by Country in 2020
Figure 37. Americas Combined Hormonal Contraceptives Sales Market Share by Type in 2020
Figure 38. Americas Combined Hormonal Contraceptives Sales Market Share by Application in 2020
Figure 39. United States Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 40. Canada Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 41. Mexico Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 42. Brazil Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 43. APAC Combined Hormonal Contraceptives Sales Market Share by Region in 2020
Figure 44. APAC Combined Hormonal Contraceptives Revenue Market Share by Regions in 2020
Figure 45. APAC Combined Hormonal Contraceptives Sales Market Share by Type in 2020
Figure 46. APAC Combined Hormonal Contraceptives Sales Market Share by Application in 2020
Figure 47. China Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 48. Japan Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 49. Korea Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 50. Southeast Asia Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 51. India Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 52. Australia Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 53. Europe Combined Hormonal Contraceptives Sales Market Share by Country in 2020
Figure 54. Europe Combined Hormonal Contraceptives Revenue Market Share by Country in 2020
Figure 55. Europe Combined Hormonal Contraceptives Sales Market Share by Type in 2020
Figure 56. Europe Combined Hormonal Contraceptives Sales Market Share by Application in 2020
Figure 57. Germany Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 58. France Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 59. UK Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 60. Italy Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 61. Russia Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 62. Middle East & Africa Combined Hormonal Contraceptives Sales Market Share by Country in 2020
Figure 63. Middle East & Africa Combined Hormonal Contraceptives Revenue Market Share by Country in 2020
Figure 64. Middle East & Africa Combined Hormonal Contraceptives Sales Market Share by Type in 2020
Figure 65. Middle East & Africa Combined Hormonal Contraceptives Sales Market Share by Application in 2020
Figure 66. Egypt Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 67. South Africa Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 68. Israel Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 69. Turkey Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 70. GCC Country Combined Hormonal Contraceptives Revenue Growth 2016-2021 ($ Millions)
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles


★調査レポート[世界の複合ホルモン避妊薬市場予測 2021年-2026年] (コード：LPI21MY9487)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の複合ホルモン避妊薬市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の脊髄くも膜下硬膜外（CSE）併用トレイ市場予測 2021年-2026年
    LPI21MY8849 / LP Information / 2021年5月 / LPインフォメーション社の「脊髄くも膜下硬膜外（CSE）併用トレイの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、標準型、カスタマイズ型など、用途別には、病院、クリニック、外来手術センターなどにセグメント区分してまとめました。脊髄くも膜下硬膜外（CSE）併用トレイのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・脊髄くも膜下硬膜外（CSE）併用トレイの世界市場概要（サマリー） ・脊髄くも膜下硬膜外（CSE）併用トレイの企業別販売量・売上 ・脊髄くも膜下硬膜外（CSE）併用トレイの企業別市場シェア ・脊髄くも膜下硬膜外（CSE）併用トレイの世界市場規模 2016年-2021年：種類別（標準型、カスタマイズ型） ・脊髄くも膜下硬膜外（CSE）併用トレイの世界市場規模 2016年-2021年：用途別（病院、クリニック、外来手術センター） ・脊髄くも膜下硬膜外（CSE）併用トレイの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・脊髄くも膜下硬膜外（CSE）併用トレイのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Combined Spinal and Epidural (CSE) Trays will have significant change from previous year. By the most conservative estimates of global Combined Spinal and Epidural (CSE) Trays market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Combined Spinal and Epidural (CSE) Trays market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth...
  • 世界のDT混合ワクチン市場予測 2021年-2026年
    LPI21MY9514 / LP Information / 2021年5月 / LPインフォメーション社の「DT混合ワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、二種類以上疾患から保護、異なる菌株・血清型による疾患から保護など、用途別には、子供、大人、高齢者、妊娠などにセグメント区分してまとめました。DT混合ワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・DT混合ワクチンの世界市場概要（サマリー） ・DT混合ワクチンの企業別販売量・売上 ・DT混合ワクチンの企業別市場シェア ・DT混合ワクチンの世界市場規模 2016年-2021年：種類別（二種類以上疾患から保護、異なる菌株・血清型による疾患から保護） ・DT混合ワクチンの世界市場規模 2016年-2021年：用途別（子供、大人、高齢者、妊娠） ・DT混合ワクチンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・DT混合ワクチンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of DT-Based Combined Vaccines will have significant change from previous year. By the most conservative estimates of global DT-Based Combined Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the DT-Based Combined Vaccines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of DT-Based Combined Vaccines market by product type,...
  • 世界のカーミング・スリーピング市場予測 2021年-2026年
    LPI21MY9459 / LP Information / 2021年5月 / LPインフォメーション社の「カーミング・スリーピングの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、医薬品、処方箋、市販薬（OTC）、睡眠研究所、睡眠時無呼吸装置、マットレス、枕など、用途別には、不眠症、睡眠時無呼吸、むずむず脚症候群（RLS）、歯ぎしり、ナルコレプシー、夢遊病などにセグメント区分してまとめました。カーミング・スリーピングのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・カーミング・スリーピングの世界市場概要（サマリー） ・カーミング・スリーピングの企業別販売量・売上 ・カーミング・スリーピングの企業別市場シェア ・カーミング・スリーピングの世界市場規模 2016年-2021年：種類別（医薬品、処方箋、市販薬（OTC）、睡眠研究所、睡眠時無呼吸装置、マットレス、枕） ・カーミング・スリーピングの世界市場規模 2016年-2021年：用途別（不眠症、睡眠時無呼吸、むずむず脚症候群（RLS）、歯ぎしり、ナルコレプシー、夢遊病） ・カーミング・スリーピングの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・カーミング・スリーピングのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Calming and Sleeping will have significant change from previous year. By the most conservative estimates of global Calming and Sleeping market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Calming and Sleeping market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Calming and Sleeping market by product type,...
  • 世界の鎮咳薬市場予測 2021年-2026年
    LPI21MY9425 / LP Information / 2021年5月 / LPインフォメーション社の「鎮咳薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、中枢作用性鎮咳薬、局所作用性鎮咳薬など、用途別には、病院薬局、小売薬局、オンライン薬局などにセグメント区分してまとめました。鎮咳薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・鎮咳薬の世界市場概要（サマリー） ・鎮咳薬の企業別販売量・売上 ・鎮咳薬の企業別市場シェア ・鎮咳薬の世界市場規模 2016年-2021年：種類別（中枢作用性鎮咳薬、局所作用性鎮咳薬） ・鎮咳薬の世界市場規模 2016年-2021年：用途別（病院薬局、小売薬局、オンライン薬局） ・鎮咳薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・鎮咳薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Antitussive Drugs will have significant change from previous year. By the most conservative estimates of global Antitussive Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Antitussive Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Antitussive Drugs market by product type, application, key manufacturers and...
  • 世界の不眠症治療薬市場予測 2021年-2026年
    LPI21MY9648 / LP Information / 2021年5月 / LPインフォメーション社の「不眠症治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、非ベンゾジアゼピン受容体作動薬、ベンゾジアゼピン受容体作動薬、選択的メラトニン受容体作動薬ラメルテオン、鎮静抗うつ薬など、用途別には、大人、子供などにセグメント区分してまとめました。不眠症治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・不眠症治療薬の世界市場概要（サマリー） ・不眠症治療薬の企業別販売量・売上 ・不眠症治療薬の企業別市場シェア ・不眠症治療薬の世界市場規模 2016年-2021年：種類別（非ベンゾジアゼピン受容体作動薬、ベンゾジアゼピン受容体作動薬、選択的メラトニン受容体作動薬ラメルテオン、鎮静抗うつ薬） ・不眠症治療薬の世界市場規模 2016年-2021年：用途別（大人、子供） ・不眠症治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・不眠症治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Insomnia Medication will have significant change from previous year. By the most conservative estimates of global Insomnia Medication market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Insomnia Medication market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Insomnia Medication market by product type, application, key manufacturers and...
  • 世界の抗HA抗体市場予測 2021年-2026年
    LPI21MY9418 / LP Information / 2021年5月 / LPインフォメーション社の「抗HA抗体の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、IgM、IgG、IgA、その他など、用途別には、治療、研究、診断などにセグメント区分してまとめました。抗HA抗体のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗HA抗体の世界市場概要（サマリー） ・抗HA抗体の企業別販売量・売上 ・抗HA抗体の企業別市場シェア ・抗HA抗体の世界市場規模 2016年-2021年：種類別（IgM、IgG、IgA、その他） ・抗HA抗体の世界市場規模 2016年-2021年：用途別（治療、研究、診断） ・抗HA抗体の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗HA抗体のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of anti-HA Antibody will have significant change from previous year. By the most conservative estimates of global anti-HA Antibody market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the anti-HA Antibody market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of anti-HA Antibody market by product type, application, key manufacturers and...
  • 世界のクラドリビン市場予測 2021年-2026年
    LPI21MY9483 / LP Information / 2021年5月 / LPインフォメーション社の「クラドリビンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、静脈内注射、皮下注射、経口錠剤など、用途別には、病院、がんセンター、その他などにセグメント区分してまとめました。クラドリビンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・クラドリビンの世界市場概要（サマリー） ・クラドリビンの企業別販売量・売上 ・クラドリビンの企業別市場シェア ・クラドリビンの世界市場規模 2016年-2021年：種類別（静脈内注射、皮下注射、経口錠剤） ・クラドリビンの世界市場規模 2016年-2021年：用途別（病院、がんセンター、その他） ・クラドリビンの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・クラドリビンのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Cladribine will have significant change from previous year. By the most conservative estimates of global Cladribine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Cladribine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Cladribine market by product type, application, key manufacturers and key regions and countries....
  • 世界の心血管疾患治療薬市場予測 2021年-2026年
    LPI21MY9466 / LP Information / 2021年5月 / LPインフォメーション社の「心血管疾患治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ヘパリン、クマディン、セクトラル、ゼベタ、ロプレッサー、トプロロールXL、ノルバスク、ロットレル、その他など、用途別には、虚血性心疾患、脂質異常症、脳卒中、血栓症、アテローム性動脈硬化症、冠状動脈疾患、末梢動脈疾患、その他などにセグメント区分してまとめました。心血管疾患治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・心血管疾患治療薬の世界市場概要（サマリー） ・心血管疾患治療薬の企業別販売量・売上 ・心血管疾患治療薬の企業別市場シェア ・心血管疾患治療薬の世界市場規模 2016年-2021年：種類別（ヘパリン、クマディン、セクトラル、ゼベタ、ロプレッサー、トプロロールXL、ノルバスク、ロットレル、その他） ・心血管疾患治療薬の世界市場規模 2016年-2021年：用途別（虚血性心疾患、脂質異常症、脳卒中、血栓症、アテローム性動脈硬化症、冠状動脈疾患、末梢動脈疾患、その他） ・心血管疾患治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・心血管疾患治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Cardiovascular Disease Drugs will have significant change from previous year. By the most conservative estimates of global Cardiovascular Disease Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Cardiovascular Disease Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Disease Drugs market by product type,...
  • 世界の医療食品市場予測 2021年-2026年
    LPI21MY9581 / LP Information / 2021年5月 / LPインフォメーション社の「医療食品の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、錠剤、粉末、その他など、用途別には、糖尿病性ニューロパチー、ADHD、アルツハイマー病、栄養不足、その他などにセグメント区分してまとめました。医療食品のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・医療食品の世界市場概要（サマリー） ・医療食品の企業別販売量・売上 ・医療食品の企業別市場シェア ・医療食品の世界市場規模 2016年-2021年：種類別（錠剤、粉末、その他） ・医療食品の世界市場規模 2016年-2021年：用途別（糖尿病性ニューロパチー、ADHD、アルツハイマー病、栄養不足、その他） ・医療食品の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・医療食品のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Medical Foods will have significant change from previous year. By the most conservative estimates of global Medical Foods market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 17920 million in 2019. Over the next five years the Medical Foods market will register a 5.6% CAGR in terms of revenue, the global market size will reach US$ 22250 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Medical Foods market by product type, application, key manufacturers and...
  • 世界の希少疾患治療薬市場予測 2021年-2026年
    LPI21MY9563 / LP Information / 2021年5月 / LPインフォメーション社の「希少疾患治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、1‰以上、0.65‰〜1‰、0.1‰以下など、用途別には、病院薬局、専門薬局、小売薬局、その他などにセグメント区分してまとめました。希少疾患治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・希少疾患治療薬の世界市場概要（サマリー） ・希少疾患治療薬の企業別販売量・売上 ・希少疾患治療薬の企業別市場シェア ・希少疾患治療薬の世界市場規模 2016年-2021年：種類別（1‰以上、0.65‰〜1‰、0.1‰以下） ・希少疾患治療薬の世界市場規模 2016年-2021年：用途別（病院薬局、専門薬局、小売薬局、その他） ・希少疾患治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・希少疾患治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Rare Disease Drug will have significant change from previous year. By the most conservative estimates of global Rare Disease Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Rare Disease Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Rare Disease Drug market by product type,...

    • ◆H&Iグローバルリサーチのお客様（例）◆